Asahi Kasei Completes Acquisition of Aicuris, Expands Antiviral Assets
Asahi Kasei has completed its acquisition of Germany’s Aicuris, adding three antiviral assets, in a deal previously reported at about €780 million.
Aicuris
Asahi Kasei Acquires Aicuris for €780 Million
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
